Renal hyperparathyroidism.
Yajima A, Tsuchiya K, Kuro-O M, Urena P, Tominaga Y, Okada M, Ichimori T, Tomosugi T, Hiramitsu T, Murata T, Nakamura M, Sasaki M, Ito A, Nitta K.
Vitam Horm. 2022;120:305-343. doi: 10.1016/bs.vh.2022.04.010. Epub 2022 Jul 22.
Laboratory screening for hyperparathyroidism.
Younes NA, Shafagoj Y, Khatib F, Ababneh M.
Clin Chim Acta. 2005 Mar;353(1-2):1-12. doi: 10.1016/j.cccn.2004.10.003.
Diagnosis of hyperparathyroidism.
Davis PJ, Davis FB.
Otolaryngol Head Neck Surg. 1985 Feb;93(1):62-4. doi: 10.1177/019459988509300112.
Normocalcemic primary hyperparathyroidism: an update.
Salcuni AS, Battista C, Pugliese F, Columbu C, Guarnieri V, Carnevale V, Scillitani A.
Minerva Endocrinol (Torino). 2021 Sep;46(3):262-271. doi: 10.23736/S2724-6507.20.03215-0. Epub 2020 Oct 26.
Sporadic and hereditary primary hyperparathyroidism.
Pepe J, Cipriani C, Pilotto R, De Lucia F, Castro C, Lenge L, Russo S, Guarnieri V, Scillitani A, Carnevale V, D'Erasmo E, Romagnoli E, Minisola S.
J Endocrinol Invest. 2011 Jul;34(7 Suppl):40-4.
MicroRNAs in parathyroid physiopathology.
Vaira V, Verdelli C, Forno I, Corbetta S.
Mol Cell Endocrinol. 2017 Nov 15;456:9-15. doi: 10.1016/j.mce.2016.10.035. Epub 2016 Nov 2.
Hypercalcaemic hyperparathyroid crisis.
Linane H, Egan AM, Griffin TP, Quill D, Phelan SM, O'Brien T.
QJM. 2015 Sep;108(9):739-40. doi: 10.1093/qjmed/hcu245. Epub 2014 Dec 17.
Primary hyperparathyroidism and familial hyperparathyroid syndromes.
Blackburn M, Diamond T.
Aust Fam Physician. 2007 Dec;36(12):1029-33.
Anemia and secondary hyperparathyroidism.
Zingraff J, Drüeke T, Marie P, Man NK, Jungers P, Bordier P.
Arch Intern Med. 1978 Nov;138(11):1650-2.
Mortality associated with primary hyperparathyroidism.
Clifton-Bligh PB, Nery ML, Supramaniam R, Reeve TS, Delbridge L, Stiel JN, McElduff A, Wilmshurst EG, Robinson BG, Fulcher GR, Learoyd D, Posen S.
Bone. 2015 May;74:121-4. doi: 10.1016/j.bone.2014.12.067. Epub 2015 Jan 27.
